MAPT and Alzheimer disease: Moreover, the positive correlation between cf-mtDNA and Aβ, together with the lack of association between cf-mtDNA and t-tau, a surrogate marker of neuro-axonal damage, indicates that a decrease in cf-mtDNA is a marker of AD pathogenesis independent of the degree of neuronal damage.